冠心病并发糖调节受损患者的冠状动脉病变分析Relationship between impaired glucose regulation (IGR) and coronary artery lesion in patients with coronary artery disease
贾淑杰,李敏,关杨,米树华,马长生
摘要(Abstract):
目的探讨冠心病并发糖调节受损患者的冠状动脉病变特点。方法回顾分析2000—2007年冠状动脉造影阳性患者720例,分为糖尿病组(208例)、糖耐量减低组(96例)、空腹血糖受损组(30例)和非糖代谢异常组(386例)。所有患者均测定空腹血糖、空腹胰岛素、餐后2h血糖、血胆固醇、三酰甘油、低密度脂蛋白、高密度脂蛋白、C反应蛋白、糖化血红蛋白,观察其年龄、冠心病危险因素(包括高血压、高胆固醇血症、体重指数和吸烟)和冠状动脉病变情况。结果 (1)4组在年龄、性别、危险因素等方面差异无统计学意义(P>0.05)。(2)平均弥漫病变血管支数分别为1.53、1.37、1.46高于非糖代谢异常冠心病组0.62(P<0.01)。(3)Logistic回归分析表明空腹胰岛素、C反应蛋白及糖化血红蛋白是弥漫冠脉病变的独立危险因子。结论糖调节受损时冠状动脉已发生严重病变,病变呈弥漫性,与糖尿病组相近。应用口服葡萄糖耐量试验试验及时发现糖代谢异常患者非常重要。
关键词(KeyWords): 冠心病;药糖耐受不良;冠状血管造影术
基金项目(Foundation):
作者(Author): 贾淑杰,李敏,关杨,米树华,马长生
参考文献(References):
- [1]Tai ES,Goh SY,LeeJJ,et al.Lowering the criterion for impaire dfasting glucose:impact on disease prevalence and associated risk of diabetes and ischemic heart disease.Diabetes Care,2004,27:1728-1734.
- [2]钱荣立,杨泽,佟之复,主编.21世纪的糖尿病防治.郑州:河南医科大学出版社,2000:3-6.
- [3]胡大一,马长生,主编.心脏病学实践2002——规范化治疗.北京:人民卫生出版社,2002:76.
- [4]Herlitz J,Malmberg K.How to improve the Cardiac prognosis for diabetes.Diabetes Care,1999,22Suppl2:B89-B96.
- [5]Grinaldi A,Gouzalez I,Bosquet F,et al.Les atteintes cardiaques dudiabetes.Presse Med,1990,19:519-524.
- [6]Henry P.Increased incidence of moderate stenosis among patients with diabetes:substrate formyocardial infarction.Heart J,1997,134:1037-1047.
- [7]杨曙光,苏玉文,张杰,等.冠心病合并2型糖尿病的冠状动脉造影分析.实用医药杂志,2002,19:154-165.
- [8]曾国彬,张玉顺,贾国良.冠心病并发II型糖尿病患者的冠状动脉造影特点.心脏杂志,2002,14:35-37.
- [9]周迎生.2型糖尿病合并冠心病临床特点的回顾性分析。中华内分泌代谢杂志,2001,17:34-35.
- [10]DECODE Study Group,the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality.Arch Intern Med,2001,161:397-404.
- [11]Bartnik M,Ryden L,Ferrari R,et al.The prevalence of abnormalglucose regulation in patients with coronary artery disease across Europe:the Euro Heart Survey on diabetes and the heart.Eur Heart J,2004,25:1880-1890.
- [12]Choi KM,Lee KW,Kim SG,et al.Inflammation,insulin resistance,and glucose in tolerance in acute myocardial infarction patients without a p revious diagnosis of diabetesmellitus.J Clin Endocrinol Metab,2005,90:175-180.
- [13]傅一明.胰岛素抵抗的研究新进展.新医学,1999,30:733-734.
- [14]李淑梅,钟世顺.胰岛素抵抗与高血压及抗高血压药物的关系.国外医学心血管疾病分册,2000,27:15-18.
- [15]Matsuzawa Y.A dispocyte function and insulin resistance.Nippon Rinsho,2000,58:338-343.